CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease
Wissenschaftlicher Artikel
Autoren
Abu-Rumeileh, Samir
Oeckl, Patrick
Baiardi, Simone
Halbgebauer, Steffen
Steinacker, Petra
Institutionen
UKU. Klinik für NeurologieErschienen in
Biomolecules ; 10 (2020), 4. - Art.-Nr. 497. - eISSN 2218-273X
Link zur Veröffentlichung
https://dx.doi.org/10.3390/biom10040497EU-Projekt
FAIR-PARK-II / Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone / EC / H2020 / 633190
Schlagwörter
biomarkers; human prion disease; Creutzfeldt-Jakob disease; Alzheimer's disease; frontotemporal dementia; neurofilament ligh chain; ubiquitin; mass spectrometry; chitinase-3-like protein 1; CREUTZFELDT-JAKOB-DISEASE; CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; BRAIN UBIQUITIN; CLASSIFICATION; EUROPEDDC-Sachgruppe
DDC 570 / Life sciencesDDC 610 / Medicine & health
Metadata
Zur LanganzeigeDas könnte Sie auch interessieren:
-
Lewy pathology and neurodegeneration in premotor Parkinson's disease
Del Tredici, Kelly; Braak, Heiko (2012)Wissenschaftlicher Artikel
-
Sonographic measurement of thickened bowel wall segments as a quantitative parameter for activity in inflammatory bowel disease
Mayer, D et al. (2000)Wissenschaftlicher Artikel
-
Spinal cord lesions in sporadic Parkinson's disease
Del Tredici, Kelly; Braak, Heiko (2012)Wissenschaftlicher Artikel